Health Care Technology
Company Overview of NextBio, Inc.
NextBio, Inc. provides a scientific platform for biologists and clinicians to aggregate and interpret genomic data for research and clinical applications. The company offers NextBio Clinical that enables the users to apply data analysis and interpretation in various ways to biomarker discovery, translational research, and clinical trials, as well as allows the correlation of patients’ molecular and clinical data from public and proprietary studies in an integrated context; and NextBio Research that provides tools and content for exploratory, preclinical, and early translational research in drug discovery and biotechnology research, as well as supports early-stage and translational discovery ...
451 El Camino Real
Santa Clara, CA 95050
Founded in 2003
Key Executives for NextBio, Inc.
Co-Founder and Vice President of Products
Chief Financial Officer and Vice President of Corporate Development
Chief Technology Officer and Vice President of Engineering
Head of Clinical Development
Compensation as of Fiscal Year 2014.
NextBio, Inc. Key Developments
Boehringer Ingelheim Renews and Expands License to NextBio Research Platform
Jul 9 13
NextBio announced that Boehringer Ingelheim has signed a multi-year renewal agreement to the NextBio Research Platform. The new agreement also expands the user base for NextBio across Boehringer Ingelheim's global research organization.
NextBio, Inc. Announces Translational Medicine Partnership with Sanofi
Apr 30 13
NextBio, Inc. announced a multi-year collaboration with Sanofi aimed at using NextBio Clinical to incorporate patient omics and clinical data into Sanofi's drug research and development, as part of Sanofi's Translational Medicine for Patients (TM4P) program. NextBio will provide Sanofi with the NextBio Clinical platform for aggregation, standardization and analysis of patient clinical data, next generation sequencing (NGS) and other molecular data across public data sources, Sanofi clinical trials and Sanofi hospital partners. NextBio's unique data integration platform, user interface and real-time Big Data analytics will allow Sanofi biologists and clinicians to tap into a vast, growing collection of patient data as it becomes available, as a key enabling technology for translational and clinical research.
NextBio, Inc. and Genophen, Inc. Form Partnership Aimed at Applying Genomics to Personalized Disease Prevention and Wellness
Apr 2 13
NextBio, Inc. and Genophen, Inc. announced a partnership aimed at furthering the adoption of genomics for disease prevention and wellness. The partnership enables Genophen to interpret full genome sequencing data from individuals through the use of the NextBio Clinical platform and to combine this data with a person's environmental, behavioral and clinical factors to create a uniquely tailored disease prevention and wellness plan for its individual members.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries